APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Radioisotopes

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Therapeutic Radioisotopes Industry Growth and Trends Forecast to 2032

Report ID 174040810120 December 2025102 pages

Choose your research edition.

Industry ResearchTherapeutic Radioisotopes Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Radioisotopes Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Therapeutic Radioisotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Radioisotopes Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Radioisotopes Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Therapeutic Radioisotopes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Therapeutic Radioisotopes include Novartis, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes, Dongcheng and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Therapeutic Radioisotopes market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Therapeutic Radioisotopes market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Therapeutic Radioisotopes market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Therapeutic Radioisotopes.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Therapeutic Radioisotopes market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Therapeutic Radioisotopes Market by Company

Novartis

Bayer

Q BioMed

Mundipharma

Lantheus

Jubilant Radiopharma

International Isotopes

Dongcheng

Curium Pharmaceuticals

China Isotope & Radiation

Aurobindo Pharma

Therapeutic Radioisotopes Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Therapeutic Radioisotopes Segment by Application

Lymphoma

Thyroid

Bone Metastasis

Other

Therapeutic Radioisotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Radioisotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Therapeutic Radioisotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lutetium-177 Table 2. Major Company of Radium-223 Table 3. Major Company of Iodine-131 Table 4. Major Company of Other Table 5. Global Therapeutic Radioisotopes Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 7. Global Therapeutic Radioisotopes Sales Market Share in Volume by Type (2021-2026) Table 8. Global Therapeutic Radioisotopes Sales by Type (2021-2026) & (US$ Million) Table 9. Global Therapeutic Radioisotopes Sales Market Share in Value by Type (2021-2026) Table 10. Global Therapeutic Radioisotopes Price by Type (2021-2026) & (US$/unit) Table 11. Global Therapeutic Radioisotopes Sales by Type (2027-2032) & (k units) Table 12. Global Therapeutic Radioisotopes Sales Market Share in Volume by Type (2027-2032) Table 13. Global Therapeutic Radioisotopes Sales by Type (2027-2032) & (US$ Million) Table 14. Global Therapeutic Radioisotopes Sales Market Share in Value by Type (2027-2032) Table 15. Global Therapeutic Radioisotopes Price by Type (2027-2032) & (US$/unit) Table 16. North America Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 17. North America Therapeutic Radioisotopes Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 19. Europe Therapeutic Radioisotopes Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Therapeutic Radioisotopes Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 23. Latin America Therapeutic Radioisotopes Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Therapeutic Radioisotopes Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Therapeutic Radioisotopes Sales by Type (2021-2026) & (US$ Million) Table 26. Therapeutic Radioisotopes Industry Trends Table 27. Therapeutic Radioisotopes Industry Drivers Table 28. Therapeutic Radioisotopes Industry Opportunities and Challenges Table 29. Therapeutic Radioisotopes Industry Restraints Table 30. Global Therapeutic Radioisotopes Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Therapeutic Radioisotopes Revenue Market Share by Company (2021-2026) Table 32. Global Therapeutic Radioisotopes Sales by Company (2021-2026) & (k units) Table 33. Global Therapeutic Radioisotopes Sales Share by Company (2021-2026) Table 34. Global Therapeutic Radioisotopes Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Therapeutic Radioisotopes Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Therapeutic Radioisotopes Major Company Production Sites and Headquarters Table 37. Global Therapeutic Radioisotopes Company, Product Type & Application Table 38. Global Therapeutic Radioisotopes Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Therapeutic Radioisotopes Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Therapeutic Radioisotopes Sales by Region (2021-2026) & (k units) Table 43. Global Therapeutic Radioisotopes Sales Market Share in Volume by Region (2021-2026) Table 44. Global Therapeutic Radioisotopes Sales by Region (2021-2026) & (US$ Million) Table 45. Global Therapeutic Radioisotopes Sales Market Share in Value by Region (2021-2026) Table 46. Global Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Therapeutic Radioisotopes Sales by Region (2027-2032) & (k units) Table 48. Global Therapeutic Radioisotopes Sales Market Share in Volume by Region (2027-2032) Table 49. Global Therapeutic Radioisotopes Sales by Region (2027-2032) & (US$ Million) Table 50. Global Therapeutic Radioisotopes Sales Market Share in Value by Region (2027-2032) Table 51. Global Therapeutic Radioisotopes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Therapeutic Radioisotopes Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 54. Global Therapeutic Radioisotopes Sales Market Share in Volume by Application (2021-2026) Table 55. Global Therapeutic Radioisotopes Sales by Application (2021-2026) & (US$ Million) Table 56. Global Therapeutic Radioisotopes Sales Market Share in Value by Application (2021-2026) Table 57. Global Therapeutic Radioisotopes Price by Application (2021-2026) & (US$/unit) Table 58. Global Therapeutic Radioisotopes Sales by Application (2027-2032) & (k units) Table 59. Global Therapeutic Radioisotopes Sales Market Share in Volume by Application (2027-2032) Table 60. Global Therapeutic Radioisotopes Sales by Application (2027-2032) & (US$ Million) Table 61. Global Therapeutic Radioisotopes Sales Market Share in Value by Application (2027-2032) Table 62. Global Therapeutic Radioisotopes Price by Application (2027-2032) & (US$/unit) Table 63. North America Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 64. North America Therapeutic Radioisotopes Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 66. Europe Therapeutic Radioisotopes Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Therapeutic Radioisotopes Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 70. Latin America Therapeutic Radioisotopes Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Therapeutic Radioisotopes Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Therapeutic Radioisotopes Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Novartis Therapeutic Radioisotopes Product Portfolio Table 77. Novartis Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Bayer Therapeutic Radioisotopes Product Portfolio Table 82. Bayer Recent Development Table 83. Q BioMed Company Information Table 84. Q BioMed Business Overview Table 85. Q BioMed Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Q BioMed Therapeutic Radioisotopes Product Portfolio Table 87. Q BioMed Recent Development Table 88. Mundipharma Company Information Table 89. Mundipharma Business Overview Table 90. Mundipharma Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Mundipharma Therapeutic Radioisotopes Product Portfolio Table 92. Mundipharma Recent Development Table 93. Lantheus Company Information Table 94. Lantheus Business Overview Table 95. Lantheus Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Lantheus Therapeutic Radioisotopes Product Portfolio Table 97. Lantheus Recent Development Table 98. Jubilant Radiopharma Company Information Table 99. Jubilant Radiopharma Business Overview Table 100. Jubilant Radiopharma Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio Table 102. Jubilant Radiopharma Recent Development Table 103. International Isotopes Company Information Table 104. International Isotopes Business Overview Table 105. International Isotopes Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. International Isotopes Therapeutic Radioisotopes Product Portfolio Table 107. International Isotopes Recent Development Table 108. Dongcheng Company Information Table 109. Dongcheng Business Overview Table 110. Dongcheng Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Dongcheng Therapeutic Radioisotopes Product Portfolio Table 112. Dongcheng Recent Development Table 113. Curium Pharmaceuticals Company Information Table 114. Curium Pharmaceuticals Business Overview Table 115. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio Table 117. Curium Pharmaceuticals Recent Development Table 118. China Isotope & Radiation Company Information Table 119. China Isotope & Radiation Business Overview Table 120. China Isotope & Radiation Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio Table 122. China Isotope & Radiation Recent Development Table 123. Aurobindo Pharma Company Information Table 124. Aurobindo Pharma Business Overview Table 125. Aurobindo Pharma Therapeutic Radioisotopes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio Table 127. Aurobindo Pharma Recent Development Table 128. North America Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. North America Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 130. North America Therapeutic Radioisotopes Sales Market Share by Country (2021-2026) Table 131. North America Therapeutic Radioisotopes Sales Forecast by Country (2027-2032) & (k units) Table 132. North America Therapeutic Radioisotopes Sales Market Share Forecast by Country (2027-2032) Table 133. North America Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Therapeutic Radioisotopes Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Therapeutic Radioisotopes Market Share by Country (2021-2026) Table 136. North America Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Therapeutic Radioisotopes Market Share Forecast by Country (2027-2032) Table 138. Europe Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Europe Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 140. Europe Therapeutic Radioisotopes Sales Market Share by Country (2021-2026) Table 141. Europe Therapeutic Radioisotopes Sales Forecast by Country (2027-2032) & (k units) Table 142. Europe Therapeutic Radioisotopes Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Therapeutic Radioisotopes Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Therapeutic Radioisotopes Market Share by Country (2021-2026) Table 146. Europe Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Therapeutic Radioisotopes Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 150. Asia-Pacific Therapeutic Radioisotopes Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Therapeutic Radioisotopes Sales Forecast by Country (2027-2032) & (k units) Table 152. Asia-Pacific Therapeutic Radioisotopes Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Therapeutic Radioisotopes Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Therapeutic Radioisotopes Market Share by Country (2021-2026) Table 156. Asia-Pacific Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Therapeutic Radioisotopes Market Share Forecast by Country (2027-2032) Table 158. Latin America Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Latin America Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 160. Latin America Therapeutic Radioisotopes Sales Market Share by Country (2021-2026) Table 161. Latin America Therapeutic Radioisotopes Sales Forecast by Country (2027-2032) & (k units) Table 162. Latin America Therapeutic Radioisotopes Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Therapeutic Radioisotopes Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Therapeutic Radioisotopes Market Share by Country (2021-2026) Table 166. Latin America Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Therapeutic Radioisotopes Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Therapeutic Radioisotopes Sales by Country (2021-2026) & (k units) Table 170. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Therapeutic Radioisotopes Sales Forecast by Country (2027-2032) & (k units) Table 172. Middle East and Africa Therapeutic Radioisotopes Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Therapeutic Radioisotopes Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Therapeutic Radioisotopes Market Share by Country (2021-2026) Table 176. Middle East and Africa Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Therapeutic Radioisotopes Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Therapeutic Radioisotopes Distributors List Table 181. Therapeutic Radioisotopes Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Therapeutic Radioisotopes Image Figure 2. Global Therapeutic Radioisotopes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Radioisotopes Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Radioisotopes Sales (2021-2032) & (k units) Figure 5. Lutetium-177 Image Figure 6. Global Lutetium-177 Sales YoY Growth (2021-2032) & (k units) Figure 7. Radium-223 Image Figure 8. Global Radium-223 Sales YoY Growth (2021-2032) & (k units) Figure 9. Iodine-131 Image Figure 10. Global Iodine-131 Sales YoY Growth (2021-2032) & (k units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Therapeutic Radioisotopes Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Therapeutic Radioisotopes Market Share by Type 2025 VS 2032 Figure 15. North America Therapeutic Radioisotopes Sales Market Share in Volume by Type in 2025 Figure 16. North America Therapeutic Radioisotopes Sales Market Share in Value by Type in 2025 Figure 17. Europe Therapeutic Radioisotopes Sales Market Share in Volume by Type in 2025 Figure 18. Europe Therapeutic Radioisotopes Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Therapeutic Radioisotopes Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Therapeutic Radioisotopes Sales Market Share in Value by Type in 2025 Figure 21. Latin America Therapeutic Radioisotopes Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Therapeutic Radioisotopes Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Therapeutic Radioisotopes Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Therapeutic Radioisotopes Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Therapeutic Radioisotopes Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Lymphoma Image Figure 28. Global Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 29. Thyroid Image Figure 30. Global Thyroid Sales YoY Growth (2021-2032) & (k units) Figure 31. Bone Metastasis Image Figure 32. Global Bone Metastasis Sales YoY Growth (2021-2032) & (k units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Therapeutic Radioisotopes Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Therapeutic Radioisotopes Market Share by Application 2025 VS 2032 Figure 37. North America Therapeutic Radioisotopes Sales Market Share in Volume by Application in 2025 Figure 38. North America Therapeutic Radioisotopes Sales Market Share in Value by Application in 2025 Figure 39. Europe Therapeutic Radioisotopes Sales Market Share in Volume by Application in 2025 Figure 40. Europe Therapeutic Radioisotopes Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Therapeutic Radioisotopes Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Therapeutic Radioisotopes Sales Market Share in Value by Application in 2025 Figure 43. Latin America Therapeutic Radioisotopes Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Therapeutic Radioisotopes Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Therapeutic Radioisotopes Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Therapeutic Radioisotopes Sales Market Share in Value by Application in 2025 Figure 47. North America Therapeutic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Therapeutic Radioisotopes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Therapeutic Radioisotopes Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Therapeutic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Therapeutic Radioisotopes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Therapeutic Radioisotopes Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Therapeutic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Therapeutic Radioisotopes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Therapeutic Radioisotopes Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Therapeutic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Therapeutic Radioisotopes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Therapeutic Radioisotopes Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Therapeutic Radioisotopes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Therapeutic Radioisotopes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Therapeutic Radioisotopes Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Therapeutic Radioisotopes Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Therapeutic Radioisotopes Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Lymphoma
  • Thyroid
  • Bone Metastasis
  • Other
Companies covered
  • Novartis
  • Bayer
  • Q BioMed
  • Mundipharma
  • Lantheus
  • Jubilant Radiopharma
  • International Isotopes
  • Dongcheng
  • Curium Pharmaceuticals
  • China Isotope & Radiation
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Therapeutic Radioisotopes Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Therapeutic Radioisotopes Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Therapeutic Radioisotopes Market by Type
  6. 1.3.1 Lutetium-177
  7. 1.3.2 Radium-223
  8. 1.3.3 Iodine-131
  9. 1.3.4 Other
  10. 1.4 Global Therapeutic Radioisotopes Market Size by Type
  11. 1.4.1 Global Therapeutic Radioisotopes Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Therapeutic Radioisotopes Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Therapeutic Radioisotopes Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Therapeutic Radioisotopes Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Therapeutic Radioisotopes Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Therapeutic Radioisotopes Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Therapeutic Radioisotopes Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Therapeutic Radioisotopes Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Therapeutic Radioisotopes Industry Trends
  2. 2.2 Therapeutic Radioisotopes Industry Drivers
  3. 2.3 Therapeutic Radioisotopes Industry Opportunities and Challenges
  4. 2.4 Therapeutic Radioisotopes Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Therapeutic Radioisotopes Revenue (2021-2026)
  2. 3.2 Global Top Players by Therapeutic Radioisotopes Sales (2021-2026)
  3. 3.3 Global Top Players by Therapeutic Radioisotopes Price (2021-2026)
  4. 3.4 Global Therapeutic Radioisotopes Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Therapeutic Radioisotopes Major Company Production Sites & Headquarters
  6. 3.6 Global Therapeutic Radioisotopes Company, Product Type & Application
  7. 3.7 Global Therapeutic Radioisotopes Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Therapeutic Radioisotopes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Therapeutic Radioisotopes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Therapeutic Radioisotopes Tier 1, Tier 2, and Tier 3
4 Therapeutic Radioisotopes Regional Status and Outlook
  1. 4.1 Global Therapeutic Radioisotopes Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Therapeutic Radioisotopes Historic Market Size by Region
  3. 4.2.1 Global Therapeutic Radioisotopes Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Therapeutic Radioisotopes Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Therapeutic Radioisotopes Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Therapeutic Radioisotopes Forecasted Market Size by Region
  7. 4.3.1 Global Therapeutic Radioisotopes Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Therapeutic Radioisotopes Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Therapeutic Radioisotopes Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Therapeutic Radioisotopes by Application
  1. 5.1 Therapeutic Radioisotopes Market by Application
  2. 5.1.1 Lymphoma
  3. 5.1.2 Thyroid
  4. 5.1.3 Bone Metastasis
  5. 5.1.4 Other
  6. 5.2 Global Therapeutic Radioisotopes Market Size by Application
  7. 5.2.1 Global Therapeutic Radioisotopes Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Therapeutic Radioisotopes Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Therapeutic Radioisotopes Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Therapeutic Radioisotopes Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Therapeutic Radioisotopes Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Therapeutic Radioisotopes Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Therapeutic Radioisotopes Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Therapeutic Radioisotopes Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Therapeutic Radioisotopes Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Therapeutic Radioisotopes Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Q BioMed
  14. 6.3.1 Q BioMed Company Information
  15. 6.3.2 Q BioMed Business Overview
  16. 6.3.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Q BioMed Therapeutic Radioisotopes Product Portfolio
  18. 6.3.5 Q BioMed Recent Developments
  19. 6.4 Mundipharma
  20. 6.4.1 Mundipharma Company Information
  21. 6.4.2 Mundipharma Business Overview
  22. 6.4.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mundipharma Therapeutic Radioisotopes Product Portfolio
  24. 6.4.5 Mundipharma Recent Developments
  25. 6.5 Lantheus
  26. 6.5.1 Lantheus Company Information
  27. 6.5.2 Lantheus Business Overview
  28. 6.5.3 Lantheus Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lantheus Therapeutic Radioisotopes Product Portfolio
  30. 6.5.5 Lantheus Recent Developments
  31. 6.6 Jubilant Radiopharma
  32. 6.6.1 Jubilant Radiopharma Company Information
  33. 6.6.2 Jubilant Radiopharma Business Overview
  34. 6.6.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio
  36. 6.6.5 Jubilant Radiopharma Recent Developments
  37. 6.7 International Isotopes
  38. 6.7.1 International Isotopes Company Information
  39. 6.7.2 International Isotopes Business Overview
  40. 6.7.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 International Isotopes Therapeutic Radioisotopes Product Portfolio
  42. 6.7.5 International Isotopes Recent Developments
  43. 6.8 Dongcheng
  44. 6.8.1 Dongcheng Company Information
  45. 6.8.2 Dongcheng Business Overview
  46. 6.8.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Dongcheng Therapeutic Radioisotopes Product Portfolio
  48. 6.8.5 Dongcheng Recent Developments
  49. 6.9 Curium Pharmaceuticals
  50. 6.9.1 Curium Pharmaceuticals Company Information
  51. 6.9.2 Curium Pharmaceuticals Business Overview
  52. 6.9.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio
  54. 6.9.5 Curium Pharmaceuticals Recent Developments
  55. 6.10 China Isotope & Radiation
  56. 6.10.1 China Isotope & Radiation Company Information
  57. 6.10.2 China Isotope & Radiation Business Overview
  58. 6.10.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio
  60. 6.10.5 China Isotope & Radiation Recent Developments
  61. 6.11 Aurobindo Pharma
  62. 6.11.1 Aurobindo Pharma Company Information
  63. 6.11.2 Aurobindo Pharma Business Overview
  64. 6.11.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio
  66. 6.11.5 Aurobindo Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Therapeutic Radioisotopes Sales by Country
  2. 7.1.1 North America Therapeutic Radioisotopes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Therapeutic Radioisotopes Sales by Country (2021-2026)
  4. 7.1.3 North America Therapeutic Radioisotopes Sales Forecast by Country (2027-2032)
  5. 7.2 North America Therapeutic Radioisotopes Market Size by Country
  6. 7.2.1 North America Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Therapeutic Radioisotopes Market Size by Country (2021-2026)
  8. 7.2.3 North America Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Therapeutic Radioisotopes Sales by Country
  2. 8.1.1 Europe Therapeutic Radioisotopes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Therapeutic Radioisotopes Sales by Country (2021-2026)
  4. 8.1.3 Europe Therapeutic Radioisotopes Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Therapeutic Radioisotopes Market Size by Country
  6. 8.2.1 Europe Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Therapeutic Radioisotopes Market Size by Country (2021-2026)
  8. 8.2.3 Europe Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Therapeutic Radioisotopes Sales by Country
  2. 9.1.1 Asia-Pacific Therapeutic Radioisotopes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Therapeutic Radioisotopes Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Therapeutic Radioisotopes Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Therapeutic Radioisotopes Market Size by Country
  6. 9.2.1 Asia-Pacific Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Therapeutic Radioisotopes Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Therapeutic Radioisotopes Sales by Country
  2. 10.1.1 South America Therapeutic Radioisotopes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Therapeutic Radioisotopes Sales by Country (2021-2026)
  4. 10.1.3 South America Therapeutic Radioisotopes Sales Forecast by Country (2027-2032)
  5. 10.2 South America Therapeutic Radioisotopes Market Size by Country
  6. 10.2.1 South America Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Therapeutic Radioisotopes Market Size by Country (2021-2026)
  8. 10.2.3 South America Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Therapeutic Radioisotopes Sales by Country
  2. 11.1.1 Middle East and Africa Therapeutic Radioisotopes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Therapeutic Radioisotopes Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Therapeutic Radioisotopes Market Size by Country
  6. 11.2.1 Middle East and Africa Therapeutic Radioisotopes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Therapeutic Radioisotopes Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Therapeutic Radioisotopes Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Therapeutic Radioisotopes Value Chain Analysis
  2. 12.1.1 Therapeutic Radioisotopes Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Therapeutic Radioisotopes Production Mode & Process
  7. 12.2 Therapeutic Radioisotopes Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Therapeutic Radioisotopes Distributors
  10. 12.2.3 Therapeutic Radioisotopes Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst